One-year real-world clinical effectiveness, safety, and laboratory safety of dupilumab in Japanese adult patients with atopic dermatitis: A single-center retrospective study

J Am Acad Dermatol. 2021 Feb;84(2):547-550. doi: 10.1016/j.jaad.2020.05.102. Epub 2020 May 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Biomarkers / blood
  • Dermatitis, Atopic / blood
  • Dermatitis, Atopic / diagnosis
  • Dermatitis, Atopic / drug therapy*
  • Dermatitis, Atopic / immunology
  • Female
  • Humans
  • Japan
  • Leukocyte Count
  • Male
  • Middle Aged
  • Retrospective Studies
  • Severity of Illness Index
  • Treatment Outcome
  • Young Adult

Substances

  • Antibodies, Monoclonal, Humanized
  • Biomarkers
  • dupilumab